Oscillating Positive Expiratory Pressure Devices Market Analysis and Forecast to 2031: By Product Type (Face Mask PEP Devices, Mouthpiece PEP Devices, Bottle PEP Devices), Indication (COPD & Asthma, Bronchitis, Cystic Fibrosis, Others), End User (Hospital

Oscillating Positive Expiratory Pressure Devices Market Analysis and Forecast to 2031: By Product Type (Face Mask PEP Devices, Mouthpiece PEP Devices, Bottle PEP Devices), Indication (COPD & Asthma, Bronchitis, Cystic Fibrosis, Others), End User (Hospital & Clinics, Ambulatory Surgical Centers, Others), and Region

The oscillating positive expiratory pressure devices market was valued at USD 125.7 million in 2021 and it is anticipated to grow further till USD 208.9 million by 2031, at a CAGR of 5.2% during the forecast period.

The machines that are utilized to remove secretions from the airways are known as oscillating positive expiratory pressure (OPEP) devices. People with chronic respiratory conditions like COPD, cystic fibrosis, and chronic bronchitis among others can benefit from it. The gadget is used to remove excess mucus that these illnesses produce. It facilitates breathing and helps to relax the lungs' walls.

Global Oscillating Positive Expiratory Pressure Devices Market Scope and Report Structure

Market Trends and Drivers

The rising incidence of cystic fibrosis and chronic obstructive pulmonary disease (COPD) is driving up demand for mucous clearing devices as OPEP devices. According to the World Health Organization (WHO), COPD exacerbations are significant occasions in the development of the disease, and the associated impairment and mortality is anticipated to raise demand for these OPEP devices globally throughout the projection period. Additionally, the innovative strategy used by major players in the development of devices and the rising use of OPEP devices among patients with respiratory disorders are to blame for the promising growth prospects.

Market Restraints and Challenges

The main issues impeding the market's growth are a lack of consumer knowledge about OPEP devices and a lack of supply of the products. The main obstacle to the market's expansion for OPEP devices is the lack of knowledge about these devices among medical professionals and patients with pulmonary disorders. Small-scale manufacturers' ineffective product marketing, the relative scarcity of efficacy evidence, and healthcare professionals' unwillingness to recommend the device to patients are frequently the causes of lower awareness.

Global Oscillating Positive Expiratory Pressure Devices Market Segmental Overview

The global oscillating positive expiratory pressure devices market is segmented into product type, indication, end user, and region.

Global Oscillating Positive Expiratory Pressure Devices Market by Product Type

Based on the product type, it is segmented into face mask PEP devices, mouthpiece PEP devices, and bottle PEP devices. The mouthpiece PEP devices segment is anticipated to dominate the market during the forecast period. Improved lung function and a decrease in pulmonary exacerbations are two benefits provided by mouthpiece PEP devices. During expiration, these devices apply back pressure to the airways. For patients with cystic fibrosis, positive expiratory pressure (PEP) devices are often superior to alternative mucous clearance methods in reducing pulmonary exacerbations.

Global Oscillating Positive Expiratory Pressure Devices Market by Indication

Based on the indication, it is segmented into COPD & asthma, bronchitis, cystic fibrosis, and others. The COPD & Asthma segment is anticipated to dominate the market during the forecast period. Due to the primary reason of tobacco use, COPD is brought on by airway blockage that makes breathing difficult. The third leading cause of death worldwide in 2019 is a chronic obstructive pulmonary disease, according to a report from the World Health Organization. Over the projected period, the segment's growth is anticipated to be boosted by increasing patient awareness of the need to create a unified platform for COPD sufferers. For instance, worldwide, November is recognized as National COPD Month. The COPD (chronic obstructive pulmonary disease) Foundation teams up with a number of respiratory healthcare organizations to organize a number of online and offline events for COPD community members to increase exposure.

Global Oscillating Positive Expiratory Pressure Devices Market by End User

Based on end user, it is segmented into hospital & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment is anticipated to dominate the market during the forecast period. Hospital oscillating positive expiratory pressure (OPEP) devices are expected to be more in demand as a result of the increase of hospitals, especially in developed countries. Furthermore, the segment's growth is supported by the presence of a well-developed infrastructure and the availability of cutting-edge equipment. Additionally, as more patients are admitted to hospitals, these devices are used more frequently, which boosts revenue in hospital pharmacies.

Geographical Analysis of the Global Oscillating Positive Expiratory Pressure Devices Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American region is anticipated to dominate the market during the forecast period. Asthma affects 1 in 13 persons, according to a 2019 report from the Centers for Disease Control and Prevention (CDC). Asthma affects more than 25 million Americans. This represents 8.4% of kids and 7.7% of adults. All age, sex, and racial groups have shown an increase in asthma cases since the early 1980s. The American Academy of Allergy, Asthma and Immunology (AAAI) estimates that in 2016, 8.3% of American children were diagnosed with asthma. Boys had an overall higher prevalence of asthma than girls, with rates of 9.2% and 7.4%, respectively. Children's asthma incidence rose from 8.7% in 2001 to 9.4% in 2010, then fell to 8.3% in 2016. Though not all adjustments were statistically significant.

Major Players in the Global Oscillating Positive Expiratory Pressure Devices Market

The major players studied in the global oscillating positive expiratory pressure devices market are AirPhysio, Allergan plc., D-R Burton Healthcare, Medica Holdings, LLC., Monaghan Medical Corporation, PARI GmbH, R. Cegla GmbH & Co. KG, Smiths Medical, Inc., and WyMedical Pty Ltd among others.

COVID-19 Impact

The COVID-19 outbreak has had a significant negative influence on the market for OPEP (Oscillating Positive Expiratory Pressure) Devices as a whole. The market for OPEP (Oscillating Positive Expiratory Pressure) Devices has been impacted by the suspension of activities in the production and end use sectors. The epidemic has had an impact on the industry's overall growth. The COVID-19 pandemic's sudden spread in 2020 and the beginning of 2021 prompted the adoption of strict lockdown laws in a number of countries, which disrupted the import and export of OPEP (Oscillating Positive Expiratory Pressure) Devices.

Recent Developments

May 2021, Monaghan Medical Corporation and Captis announced their agreement to a three year contract creating a partnership between the industry leaders. The sole source agreement recognizes the value of Monaghan’s patient outcome evidence and gold standard Medical Devicess, with Captis’ desire to drive process efficiencies and value driven healthcare spending.

February 2020, Smiths Medical Announced Launch Of Oscillatory Positive Expiratory Pressure Educational Programme On Doctors.net.uk

Frequently Asked Questions

Q1. How big is the Oscillating Positive Expiratory Pressure Device market?

Ans. The global Oscillating Positive Expiratory Pressure Device market size was USD 125.7 million in 2021 and it is anticipated to grow further till USD 208.9 million by 2031, at a CAGR of 5.2% from 2022 to 2031.

Q2. What is the Oscillating Positive Expiratory Pressure Device market growth rate?

Ans. The growth rate of the Oscillating Positive Expiratory Pressure Device market is 5.2%.

Q3. Which region holds a major market share for the Oscillating Positive Expiratory Pressure Device market?

Ans. North America holds a major market share of the Oscillating Positive Expiratory Pressure Device market in 2021.

Q4. Which segment accounted for the largest Oscillating Positive Expiratory Pressure Device market share?

Ans. By end use, the hospitals & clinics segment accounted for the largest Oscillating Positive Expiratory Pressure Device market share.

Q5. Who are the key players in the Oscillating Positive Expiratory Pressure Device market?

Ans. The global Oscillating Positive Expiratory Pressure Device market report includes players such as AirPhysio, Allergan plc., D-R Burton Healthcare, Medica Holdings, LLC., Monaghan Medical Corporation, PARI GmbH, R. Cegla GmbH & Co. KG, Smiths Medical, Inc., and WyMedical Pty Ltd among others.

Q6. What are the factors driving the Oscillating Positive Expiratory Pressure Device market growth?

Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.

Q7. What are the key growth strategies of Oscillating Positive Expiratory Pressure Device market players?

Ans. The key growth strategies of Oscillating Positive Expiratory Pressure Device market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Oscillating Positive Expiratory Pressure Device market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Oscillating Positive Expiratory Pressure Device market during the forecast period.